The Imp.Ac.T.project. Improving Access to HIV/TB Testing for marginalized groups

Similar documents
Evaluation report of the Imp.Ac.T. Project

Strategies of drug users to avoid infection with hepatitis C

Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite

EMPOWERING CIVIL SOCIETY AND PUBLIC HEALTH SYSTEM TO FIGHT TUBERCULOSIS EPIDEMIC AMONG VULNERABLE GROUPS

HIV testing in Europe: From policy to effectiveness

Overall aim Improving the access to and the quality of health and social services for marginalised people

Hepatitis prevention in the context of HIV prevention point work in Latvia

NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA

HepC Break Through project

Poland nationalupdate

Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014

Diagnosis of HIV and TB in the Finnish primary health care. Pekka Suomalainen M.D

Pilot Condom Distribution in Czech Prison

Models of good practice in drug treatment in Europe. Project group

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

Drug Policy and the HIV Movement. SAULIUS CAPLINSKAS MD, PhD

HIV/AIDS, STI, hepatitis

Drug Consumption Rooms Worldwide

ECDC and Spanish Ministry of Health workshop:

IDU Outreach Project. Program Guidelines

Summary Report: Survey of Hepatitis C Virus counseling and testing services at HIV counseling and testing sites, and health service sites.

Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre

No Wrong Door Integrative Screener 1.0 Feedback Sheet 01/14/15

TB: INTEGRATION IN HARM REDUCTION PACKAGES. ICF "AIDS Foundation East-West (AFEW Ukraine) Tbilisi, 2015

Joint Action on HIV and co-infection prevention and harm reduction HA-REACT

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision

epidemic among vulnerable groups

Guidelines For Services Providing Injecting Equipment

Recent trends in drug problems and service provision in Greece

HepTalk Listserv Archive August 2005

HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons

HIV, HBV and HCV testing policy experiences and lessons learned.

Additional North Carolina Projects

Improving access of migrant populations to HIV Services in the Caribbean 09/ /2013

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg

The birthof the Dutch National hepatitis plan

Outline. RAND Survey of Homeless Youth. Past Month Substance Use. Los Angeles County. Developing Effective Risk Reduction Programs for Homeless Youth

TB/HIV in the WHO European Region Overview, Priorities & Response

Mid study Advisory Group Meeting, 14 th February 2011

Experiences of site visits to Estonian low threshold service centres - improving TB case-finding and infection control

Evaluating the impact of an HIV& AIDS Community Training Partnership Programme (CTPP) in five diamond mining communities in South Africa

ECDC s role in the fight against HIV/AIDS in Europe

Understanding your epidemic: WHO tools for hepatitis surveillance

Dear all, For the service user survey:

Hepatitis C treatment program improves access to housing, income and healthcare

Narrative report of HIV Preventive programmes in the Slovak Republic as of 31-st December 2013

New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016

QuADS Organisational Standards and Professional Competencies in needle exchange

Primary Care Services for blood borne viral hepatitis prevention, treatment and care

THE PORTUGUESE COMMUNITY SCREENING NETWORK

VHPB MEETING ANTWERP 2014 ACHIEVEMENTS AND CHALLENGES IN PREVENTION AND CONTROL OF VIRAL HEPATITIS

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

Note: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.

Action Plan on HIV/AIDS in the EU and neighbouring countries:

Current Hepatitis B and C Screening Practices for Migrants and Barriers to Screening

HIV Prevention Service Provider Survey 2014

SUBJECT: Hepatitis C Virus (HCV) Counseling/Education, Testing, Referral, and Partner Notification

3 rd EACS Standard of care for HIV and co-infections, Bucharest, 2019

As a result of this training, participants will be able to:

Supporting Effective PrEP Pill Taking and Providing HIV Risk Reduction Counselling.

Global strategy on viral hepatitis and regional action plan: monitoring framework and 10 core indicators

As a result of this training, participants will be able to:

Using Rapid Assessment and Response Methodology: Waterloo Region's Experience Ontario Harm Reduction Distribution Program Conference

Bio-behavioural study among MSM in European cities. Think Tank Meeting November 25 th, 2015

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)

Syringe type and HIV risk: current knowledge and future directions

NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen

Housing / Lack of Housing and HIV Prevention and Care

Saskatchewan HIV Strategy: Social Network Approach

KAZAKHSTAN. National Focal Point. Drug Abuse and Drug Dependence Treatment Situation. Territory : 2,717,300 km 2 Capital: Astana BASIC DATA

IPT BOTSWANA EXPERIENCE

HIV Pre- Exposure Prophylaxis

HIV in Prison Situation in Frankfurt am Main

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

Towards universal access

The 2010 Wirral Smokers Panel Survey: Smoking Prevalence, Intentions to Quit and Attitudes to Your Reason Your Way Campaign

Quantitative Approaches to ERRE

MARA referral M&E Framework with recommended indicators & sources of data

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)

TB in Corrections Phoenix, Arizona

Primary and secondary hepatitis prevention and control programmes The Netherlands

HIV Testing Survey, 2002

How does cannabis affect my work performance?

Health Care Workers and Viral Hepatitis in Turkey. Bulent Degertekin M.D. Viral Hepatitis Prevention Board Meeting

Opinion. Vaccination Programmes and Health Systems in the EU. Expert Panel on Effective Ways of Investing in Health

New EU Health Programme: funding mechanisms for civil society working on HIV and related areas

PHSKC HIV Testing Survey: Knowledge, Attitudes and Practices

Testing, Prevention and Care IDU in Chicago, 2009

TB/HIV policy monitoring & advocacy - an HIV institutional perspective. Alasdair Reid

Seizing the Opportunity: Working with Adolescent Boys for an HIV-Free Generation

The Barents Tuberculosis Program. The Barents Euro-Arctic Council Joint Working Group on Health and Related Social Issues

Questions may be directed totamara Chipperfield, Director of Mental Health and Addictions

IMPACT EVALUATION OF PERFORMANCE BASE FINANCING

Building and enhancing capacity for HCV prevention; BC case scenario

HIV risk associated with injection drug use in Houston, Texas 2009: A Latent Class Analysis

Improving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal. Henrique Barros

EMCDDA looks behind rising numbers of young people in cannabis treatment

Sharing the Harvest project: independent evaluation summary

Hepatitis C Strategy. About us. What is hepatitis C?

COUNTRY TABLE. MONTENEGRO.

Transcription:

The Imp.Ac.T.project Improving Access to HIV/TB Testing for marginalized groups Presentation at DRID meeting EMCDDA 11 Oct. 2012 -Jenneke van Ditzhuijzen Acknowledgments: The Project Imp.Ac.T. Improving Access to HIV/TB testing for marginalized groups (Ref.: 2009 12 01) has received funding from the European Commission under the Health Programme 2008-2013. However, the sole responsibility for the study lies with the author and the European Commission is not responsible for any use that may be made of the information contained therein.

Presentation Outline 1. Describe project 2. Methods 3. Results (preliminary) 4. Discussion and recommendations

Project partners Villa Maraini Italy, Rome Project Leader + Implementation Gruppo Abele Italy, Turin Implementation Sananim Odyseus Foundation De Regenboog Groep (FRG) Czech Rep., Prague Slovakia, Bratislava Netherlands, Amsterdam Implementation Implementation Project Evaluation

Project Aims General aim: To broaden the access to HIV and TB testing, prevention, treatment and care for vulnerable groups (PDU s, migrant DU s). ( the mountain comes to moses ) Specific objectives: 1. Development of framework (guidelines/tools) 2. Increase access to HIV and TB testing for PDU s and migrant DU s 3. To ensure treatment for HIV/ TB for PDU s and migrant DU s 4. To promote healthier ways of life and risk reduction among PDU s and migrants 5. To assess the effectiveness of HIV/ TB street testing in terms of proportion of new infections identified

Important to know Imp.Ac.T. is a PILOT project Start from scratch: development, implementation and evaluation in 2 years Recruitment, testing, counseling and data collection all done by low threshold services staff Tools developed in meetings and with advice Advisory Board: members from EAHC, EMCDDA, ECDC, WHO Europe, L. Spallanzani, IFRC, and others.

Activities Phase 1: Development 9/2010-5/2011 Recruitment method Pre- and post test counseling Questionnaire Database Testing methods Follow up methods Focus groups topic lists Training staff (manual) Phase 2: Implementation 5/2011-6/2012 Phase 3: Evaluation - reporting 6/2012-11/2012

Method: recruitment Recruitment by low threshold service staff On streets, in needle exchange Promotion: information flyers, posters Response Monitoring Form Eligibility Willingness Basic demographics

Method: counseling According to international (WHO) guidelines Information & motivation After testing: also education preventive hygiene WHO (2010). Scaling up HIV testing and counseling in the WHO European Region as an essential component of efforts to achieve universal access to HIV prevention, treatment, care and support. Policy framework.

Method: HIV testing Rapid test DETERMINE HIV 1/2 High sensitivity (100%) and specificity (99.75%) Result in 20 minutes From www.determinetest.com

Method: TB testing 1. Clinical screening:risk assessment (+ physical examination) by doctor/ nurse 2. Sputum collection: in case of positive screening; 2 sputum samples at different times 3. Lab result in 3-6 weeks Note: Active (not latent) TB test In Prague no sputum test but referral to X-ray

Method: Questionnaire Based on DRID-tool and other similar questionnaires Administration in waiting time for HIV test results Follow up questionnaire Database: Developed by VM on website Survey tool developed by Sananim for direct administration

Method: FOCUS GROUPS First train-the-trainer (partners) Staff training 1 moderator, 1 observer Audio recorded Reporting format: Summary and exact quotes Topics introduced with open questions Guide discussion (without adding to it) No mention of project Education after FG

Method: FOCUS GROUPS 4 focus groups per city T1: 2 before implementation (1 HIV, 1 TB) T2: 2 after implementation (1 Imp.Ac.T. Participants, 1 others) Topics Knowledge on TB/HIV Access to facilities After implementation: perceived behaviour change After implementation: evaluation by participants

Presentation Outline 1. Describe project 2. Methods 3. Results (preliminary) 4. Discussion and recommendations

This image cannot currently be displayed. This image cannot currently be displayed. Preliminary results Sample size

Preliminary results Socio-demographics (PDU): Mostly male (73%), 25-34 years old (41%), often homeless (43%), secondary school education level (50%), unemployed (67%) or undeclared work/sex worker (17%). Small percentages of migrants in Bratislava (3%) and Prague (6%), higher in Rome (16%) and Turin (25%). Non-pdu s are slightly more often homeless or sex worker.

This image cannot currently be displayed. This image cannot currently be displayed. Preliminary results HIV test results

This image cannot currently be displayed. Preliminary results TB test results

This image cannot currently be displayed. image cannot currently be displayed. Preliminary results Descriptives HIV+ people (n=19) This

Preliminary results Behavioural data: Drug Use This image cannot currently be displayed.

Preliminary results Behavioural data: Risk behaviour Needle sharing Prison ever: 60% (from 38% in Rome to 77% in Bratislava) last 4 weeks: 13% (from 10% in Rome to 28% in Bratislava) At follow up 15% was still sharing needles! 52% has ever been in prison 25 % has injected drugs in prison Condom use sex workers and their clients about half the time to mostly (m=3.6) casual partners occasionally to about half the time (m=2.7) STD infection last 12 months: 6%

Preliminary results Behavioural data: HIV testing behaviour 79% had HIV test before (Bratislava lowest 55%) Reasons NOT to get tested (barriers) I don t think I m infected (284) Other priorities; e.g., scoring drugs (78) I m afraid to do the test (51) Institutional barriers NOT IMPORTANT AT ALL,only in Turin (a bit, mainly migrants) Intention to continue retesting regularly: 72% yes/ quite likely HIV risk behaviour change: 60% not at all

Preliminary results Behavioural data: TB testing behaviour 49% vaccinated for TB, another 26% possibly vaccinated TB tested before: 53% Reasons NOT to get tested (barriers) I don t think I m infected (766) Other priorities; e.g., scoring drugs (188) Again, institutional barriers NOT IMPORTAN Intention to continue retesting regularly: 22% yes/ quite likely TB knowledge change: 78% not at all

Preliminary results Focus groups Poor knowledge on TB disease from the past Rich knowledge on HIV we know more than non-users Barriers: not institutional, but in themselves: I will go tomorrow No behaviour change between T1 and T2 Positive evaluation of project (incentives!) Should be continued Add HCV test (instead of TB?)

Summary and Discussion HIV 19 new infections found in 2191 PDU s 16 new infections found in 1809 recent IDU s --> less than 1% incidence No TB infection -why not? only active TB after screening; low accuracy of sputum test??? TB prevalence seems low??? relatively small migrant population???

So... What about the project aims? General aim: To broaden the access to HIV and TB testing, prevention, treatment and care for vulnerable groups ((P)DU s, migrant DU s). Specific objectives: 1. Development of framework (guidelines/tools) 2. Increase access to HIV and TB testing for PDU s and migrant DU s 3. To ensure treatment for HIV/ TB for PDU s and migrant DU s 4. To promote healthier ways of life and risk reduction among PDU s and migrants 5. To assess the effectiveness of HIV/ TB street testing in terms of proportion of new infections identified We reached objectives 1, 2 and 5 3 and 4 partly: Ensuring treatment is a challenge Changing health behaviour is a slow process

Lessons and recommendations Value of Imp.Ac.T. Project example of street intervention/data collection combi social workers as interviewers interviewing improved relationship with clients Improvements conflicting role interviewer - social worker response monitoring: a lot of work! TB very hard to diagnose, no rapid test for active TB baseline data and good preparation essential (involve experts!) computer-assisted survey tool recommended